Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
ResMed Inc., a medical equipment company incorporated in Delaware and listed on the New York Stock Exchange under the symbol RMD, has filed its annual report with the SEC for the fiscal year ending June 30, 2024. The report confirms ResMed’s compliance with all required filings and internal control effectiveness, and discloses a robust market value of over $25 billion as of December 2023. The company’s common stock is actively traded and, excluding treasury shares, has nearly 147 million shares issued and outstanding.
For further insights into AU:RMD stock, check out TipRanks’ Stock Analysis page.